Teladoc Health Inc.

AI Score

XX

Unlock

6.83
-0.07 (-1.01%)
At close: Apr 17, 2025, 3:59 PM
6.83
0.00%
After-hours: Apr 17, 2025, 07:57 PM EDT

Teladoc Health Statistics

Share Statistics

Teladoc Health has 175.28M shares outstanding. The number of shares has increased by 2.41% in one year.

Shares Outstanding 175.28M
Shares Change (YoY) 2.41%
Shares Change (QoQ) 0.87%
Owned by Institutions (%) 75.04%
Shares Floating 173.46M
Failed to Deliver (FTD) Shares 292
FTD / Avg. Volume < 0.01%

Short Selling Information

The latest short interest is 21.72M, so 12.51% of the outstanding shares have been sold short.

Short Interest 21.72M
Short % of Shares Out 12.51%
Short % of Float 16.18%
Short Ratio (days to cover) 4.38

Valuation Ratios

The PE ratio is -1.55 and the forward PE ratio is -8.04. Teladoc Health's PEG ratio is 0.

PE Ratio -1.55
Forward PE -8.04
PS Ratio 0.6
Forward PS 0.4
PB Ratio 1.04
P/FCF Ratio 5.48
PEG Ratio 0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Teladoc Health.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.77, with a Debt / Equity ratio of 1.06.

Current Ratio 1.77
Quick Ratio 1.73
Debt / Equity 1.06
Debt / EBITDA -2.7
Debt / FCF 5.6
Interest Coverage -42.89

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $556.18K
Profits Per Employee $-216.72K
Employee Count 4,620
Asset Turnover 0.73
Inventory Turnover 19.7

Taxes

Income Tax 7.59M
Effective Tax Rate -0.76%

Stock Price Statistics

The stock price has increased by -48.18% in the last 52 weeks. The beta is 1.74, so Teladoc Health's price volatility has been higher than the market average.

Beta 1.74
52-Week Price Change -48.18%
50-Day Moving Average 9.49
200-Day Moving Average 9.2
Relative Strength Index (RSI) 31.18
Average Volume (20 Days) 7.92M

Income Statement

In the last 12 months, Teladoc Health had revenue of 2.57B and earned -1B in profits. Earnings per share was -5.87.

Revenue 2.57B
Gross Profit 1.82B
Operating Income -1.02B
Net Income -1B
EBITDA -587.01M
EBIT -969.85M
Earnings Per Share (EPS) -5.87
Full Income Statement

Balance Sheet

The company has 1.3B in cash and 1.58B in debt, giving a net cash position of -286.29M.

Cash & Cash Equivalents 1.3B
Total Debt 1.58B
Net Cash -286.29M
Retained Earnings -16.23B
Total Assets 3.52B
Working Capital 722.37M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 293.68M and capital expenditures -10.79M, giving a free cash flow of 282.89M.

Operating Cash Flow 293.68M
Capital Expenditures -10.79M
Free Cash Flow 282.89M
FCF Per Share 1.66
Full Cash Flow Statement

Margins

Gross margin is 70.76%, with operating and profit margins of -39.73% and -38.97%.

Gross Margin 70.76%
Operating Margin -39.73%
Pretax Margin -38.67%
Profit Margin -38.97%
EBITDA Margin -22.84%
EBIT Margin -39.73%
FCF Margin 11.01%

Dividends & Yields

TDOC does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for TDOC is $10, which is 46.4% higher than the current price. The consensus rating is "Hold".

Price Target $10
Price Target Difference 46.4%
Analyst Consensus Hold
Analyst Count 18
Stock Forecasts

Scores

Altman Z-Score -6.02
Piotroski F-Score 3